Rapid growth in the geriatric population, rising prevalence of eye diseases, limited number of ophthalmologists, government initiatives to encourage the adoption of EHR/EMR, and the increasing adoption of teleophthalmology are the factors driving the growth of the ophthalmology PACS market.
The Ophthalmology
PACS market is projected to reach USD 160.2 million by 2023 from an
estimated USD 101.0 million in 2017, at a CAGR of 8.5% during the forecast
period
Ask for PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=130879968
The integrated PACS segment is expected to dominate the
ophthalmology PACS market in 2018.
Based
on type, the ophthalmology PACS market is segmented into standalone and
integrated PACS. Among these, the integrated PACS segment is expected to
command the largest share of the ophthalmology PACS market in 2018. The
advantages associated with the use of integrated PACS, such as ease of
deployment and use, easy interoperability, data security, portability, and
cost-effectiveness are driving the growth of this segment.
Based on delivery model, the web/cloud-based PACS segment is
projected to grow at the highest CAGR during the forecast period.
Based
on delivery model, the ophthalmology PACS market is segmented into on-premise
and web/cloud-based models. The web/cloud-based PACS segment is expected to
grow at the highest CAGR during the forecast period. The high growth rate can
be attributed to the fact that, these models do not require any significant
setup charges. Maintenance and support service charges are also included in
subscription fees, which make these delivery models more affordable for
customers.
The specialty clinics & ambulatory surgery centers segment is
expected to dominate the ophthalmology PACS market in 2018.
Based
on end user, the ophthalmology PACS market is segmented into hospitals,
specialty clinics & ambulatory surgery centers, and other end users. In
2018, the specialty clinics & ambulatory surgical centers segment is
expected to command the largest share of the ophthalmology PACS market. The
growing patient pool for the diagnosis and treatment of cataracts in specialty
clinics & ASCs due to cost-effective treatments is expected to propel the
growth of the ophthalmology PACS market in this end-user segment.
North America to dominate the market in 2018
In
2018, North America is expected to command the largest share of the market.
With the growing aging population and increasing incidence of age-related eye
diseases, the demand for technologies such as PACS is increasing in the North
American region. Additionally, government initiatives towards digitization and
increasing adoption of EHR/EMR and data storage & exchange solutions are
the additional factors driving the adoption of ophthalmology PACS in this
region.
Request for Sample Pages :-
https://www.marketsandmarkets.com/requestsampleNew.asp?id=130879968
While
the ophthalmology PACS market represents significant growth opportunities,
market growth may be hindered due to the high implementation and maintenance
costs of these solutions.
The
ophthalmology PACS market is marked by the presence of several big and small
players. Prominent players in this market include Carl Zeiss Meditec AG
(Germany), Topcon Corporation (Japan), Heidelberg Engineering (Germany),
Sonomed Escalon (US), Visbion (UK), EyePACS (US), and IBM Corporation (Merge
Healthcare) (US).
No comments:
Post a Comment